An Interview on Sustainability in Endotoxin Testing

[Article Title]

The pharmaceutical industry is shifting from traditional horseshoe crab blood-based LAL testing to sustainable, animal-free alternatives for endotoxin detection. In this exclusive interview, Charles River Labs' Product Manager Courtney Wachtel discusses key regulatory milestones—including the landmark USP Chapter <86> guidance from May 2025—and how recombinant testing methods are gaining global traction. She also reveals an innovative cartridge recycling program that addresses plastic waste while maintaining validated workflows. Learn about the challenges still facing full industry adoption, customer feedback on these sustainability initiatives, and what the next decade holds for harmonizing patient safety with environmental responsibility.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Please enter the phone number you would like to be contacted at.

  • Yes, I would like to receive email communications from Charles River and allow for my information to be used for any follow-up requests to identify potential products or services relevant to my needs.
    • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.